Atlas Trials

A Phase 1b Study of ARGX-111 in Patients With Advanced Cancer.

Clinical trial NCT02055066 · COMPLETED

Trial details

NCT number
NCT02055066
Sponsor
argenx
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2014-01-01
Primary completion
2017-03-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.